MTS Health Fund IV closes at $365 mln

MTS Health Investors said Oct. 5 that it closed its fourth fund with $365 million in LP and GP commitments. MTS Health Investors IV LP was oversubscribed and closed at its fundraising cap. The fund will continue MTS’s focus on the healthcare services sector. Kirkland & Ellis LLP served as legal counsel while Probitas Partners acted placement agent.


New York, October 5, 2016 — MTS Health Investors, LLC (“MTS”), the healthcare-focused private equity fund, announced today the closing of its fourth fund, MTS Health Investors IV, L.P. (“Fund IV”) with $365 million in limited partner and general partner commitments. The fund was oversubscribed and closed at its fundraising cap.
Senior Managing Director, Curtis S. Lane, said, “We are grateful for the ongoing support of our existing investors and pleased to add a distinguished group of new investors to this fund. MTS recognizes the confidence our partners have placed in us and will continue to work diligently to execute our strategy.”
Fund IV will continue MTS’s focus on investing in businesses that operate in the services sectors of healthcare. Although the healthcare industry is expanding, not all areas of healthcare are equally positioned for rapid growth. MTS targets sectors that are poised to benefit from the strongest industry tailwinds and companies that differentiate themselves by delivering innovative and cost-effective solutions.
The senior investment team at MTS has been investing together for over a decade and has over 80 years of combined experience working with healthcare businesses. Oliver T. Moses, MTS’s Senior Managing Director, said, “MTS’s deep domain knowledge and extensive network of healthcare industry relationships equips us to identify attractive investment targets and to bring new growth opportunities to each of the companies with which we partner. We believe that this approach complements our strengths and will continue to deliver value.”
Kirkland & Ellis LLP served as legal counsel in the fund formation of Fund IV and Probitas Partners served as placement agent.

About MTS Health Investors, LLC
MTS Health Investors, LLC (“MTS”) makes equity investments in companies that operate within the services sectors of the healthcare industry. We focus on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions.
MTS manages over $700 million in investments and is currently investing out of its fourth fund. We are based in New York City and invest in companies throughout the United States.